Clinical Trials Browser

Phase 2/3 × Liver Neoplasms × Sorafenib × Clear all

NCT05033522 2025-10-23

ALIVE

Phase 2/3 Suspended

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01932385 2018-02-14

Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma

Phase 2/3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01901692 2017-09-18

START

Phase 2/3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms